As pharma marketers spend more on digital promotions, their value rises for competitive intel
Dunn Group (Totowa, NJ) which has provided custom competitive-intelligence services (CIS) for life sciences marketers going back to the late 1980s, is introducing a new CIS tool: MDMessageTRAC. The product is customized in that it is media- and therapeutic-class-specific, but standardized in that it uses essentially the same methodology for each client: soliciting a panel of physicians, and then obtaining direct feedback from them, on a schedule, for what messaging and promotional materials pharma reps are showing them. Physicians on such panels receive a stipend from Dunn Group.
Although a fairly straightforward research method, this service has not been offered previously, says Stuart Friedman, Dunn president. The growth of digital media presentations, such as those presented on interactive tablets like iPads, might be a factor; as more pharma marketers invest more resources in these presentations, their CIS value increases. The benefits are obvious, he says: Product or brand managers can get rapid feedback on what their competitors are saying about them, and what messages make the strongest impact on physicians observing these presentations.
Analysts working within Dunn receive the physician feedback and then synthesize a report summarizing key trends; Friedman says this contrasts with automated systems tracking--for example, online messaging activity or social media channels. (However, companies in that business also claim a high degree of fidelity to what the buzz about a product is.) A client helps Dunn set up the program by providing its own information on key opinion leaders or prescribers that could be on the panels. Costs are in the mid-five-figure range for an annual service that would provide a number of “cycles,” or update periods, such as monthly or quarterly.
LogiPharma Unpacked: Highlights, Key Insights, and the Road to 2025
October 16th 2024In this special post-show episode, we sit down with Ryan Portela, Head of Production for LogiPharma, to reflect on the highlights and key takeaways from this year’s event. From attendee feedback to the most impactful sessions, Ryan shares insider insights and discusses how the momentum from 2024 will continue to shape the future of pharma supply chains. Plus, get a sneak peek into the exciting plans for LogiPharma's 20th Anniversary in 2025.
Reimagining Closed-Loop Marketing Strategies for Pharma Companies
November 21st 2024The pharmaceutical industry is evolving, and so are the strategies needed to connect with healthcare professionals. Closed-loop marketing (CLM) has become essential in delivering personalized, data-driven engagement that resonates with physicians and improves key outcomes, such as enhancing patient care, increasing
Maximize Pharma’s Potential with AI-Ready Data for Commercial Excellence
November 21st 2024As the pharmaceutical industry embraces the power of AI, having data that’s large, diverse, and well-structured is critical for driving innovation and improving outcomes. Ensuring your data is AI-ready and can be used with more advanced solutions enables your teams to make informed strategic decisions, predict trends, enhance customer engagements and drive overall strategy.